A new combination of drugs has been developed that may overcome treatment resistance and relapse in breast cancer. While most women initially respond well to hormonal treatment with drugs such as tamoxifen, many go on to develop resistance and relapse.
http://ift.tt/1HMVN9o
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
The Raw Stem Cell News Feed
The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Subscribe to:
Post Comments (Atom)
Popular Stem Cell Roundup Posts
-
... president Enrico Garaci , who has served since 2001, has been attacked over his aversion to embryonic stem cell research and reluctance ...
-
... which an excellent scientific environment exists. Experience in the field of vascular neuroscience and/or stem cell research is helpful ...
-
... UC San Diego, there is a representative for each institute, because those are the people who know about stem cell research," said U...
-
... to avoid the appearance of conflict of interest. California has transformed into a powerhouse player in stem cell research, but the taxp...
-
Elijah Talley, 11, was diagnosed with stage 4 neuroblastoma at the age of 4. He has spent a majority of the last few years in the hospital r...
-
... voters approved Proposition 71 in 2004, authorizing the state to issue $3 billion in bonds to support stem cell research in California (...
-
Frank Farmer named to the Board Of Directors of World Stem Cell Institute, Inc. a 501 non-profit corporation involved in Stem Cell research,...
-
Patrys Limited , a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in mu...
-
Considerable advances have taken place since the initial isolation and characterization of human embryonic stem cells; however, significant ...
-
... Tools in Genetic Engineering 8. Microbial Genetics 9. Plant Genetic Engineering 10. Genetic Engineering & Stem Cell Research 11. Clo...
No comments:
Post a Comment